rs7725218
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_198253.3(TERT):c.1769+130C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.353 in 955,560 control chromosomes in the GnomAD database, including 60,792 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.38 ( 10717 hom., cov: 33)
Exomes 𝑓: 0.35 ( 50075 hom. )
Consequence
TERT
NM_198253.3 intron
NM_198253.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.977
Publications
54 publications found
Genes affected
TERT (HGNC:11730): (telomerase reverse transcriptase) Telomerase is a ribonucleoprotein polymerase that maintains telomere ends by addition of the telomere repeat TTAGGG. The enzyme consists of a protein component with reverse transcriptase activity, encoded by this gene, and an RNA component which serves as a template for the telomere repeat. Telomerase expression plays a role in cellular senescence, as it is normally repressed in postnatal somatic cells resulting in progressive shortening of telomeres. Deregulation of telomerase expression in somatic cells may be involved in oncogenesis. Studies in mouse suggest that telomerase also participates in chromosomal repair, since de novo synthesis of telomere repeats may occur at double-stranded breaks. Alternatively spliced variants encoding different isoforms of telomerase reverse transcriptase have been identified; the full-length sequence of some variants has not been determined. Alternative splicing at this locus is thought to be one mechanism of regulation of telomerase activity. [provided by RefSeq, Jul 2008]
TERT Gene-Disease associations (from GenCC):
- pulmonary fibrosis and/or bone marrow failure, Telomere-related, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- dyskeratosis congenita, autosomal dominant 2Inheritance: AR, AD, SD, Unknown Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Laboratory for Molecular Medicine
- acute myeloid leukemiaInheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- dyskeratosis congenitaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Hoyeraal-Hreidarsson syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- melanoma, cutaneous malignant, susceptibility to, 9Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 5-1282299-G-A is Benign according to our data. Variant chr5-1282299-G-A is described in ClinVar as Benign. ClinVar VariationId is 1280138.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.427 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TERT | NM_198253.3 | c.1769+130C>T | intron_variant | Intron 3 of 15 | ENST00000310581.10 | NP_937983.2 | ||
| TERT | NM_001193376.3 | c.1769+130C>T | intron_variant | Intron 3 of 14 | NP_001180305.1 | |||
| TERT | NR_149162.3 | n.1848+130C>T | intron_variant | Intron 3 of 12 | ||||
| TERT | NR_149163.3 | n.1848+130C>T | intron_variant | Intron 3 of 12 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.375 AC: 57018AN: 151948Hom.: 10704 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
57018
AN:
151948
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.349 AC: 280301AN: 803494Hom.: 50075 AF XY: 0.352 AC XY: 148187AN XY: 420532 show subpopulations
GnomAD4 exome
AF:
AC:
280301
AN:
803494
Hom.:
AF XY:
AC XY:
148187
AN XY:
420532
show subpopulations
African (AFR)
AF:
AC:
8827
AN:
20664
American (AMR)
AF:
AC:
10722
AN:
36762
Ashkenazi Jewish (ASJ)
AF:
AC:
8475
AN:
21510
East Asian (EAS)
AF:
AC:
12787
AN:
35126
South Asian (SAS)
AF:
AC:
28490
AN:
69116
European-Finnish (FIN)
AF:
AC:
15952
AN:
44734
Middle Eastern (MID)
AF:
AC:
1316
AN:
2994
European-Non Finnish (NFE)
AF:
AC:
179507
AN:
534032
Other (OTH)
AF:
AC:
14225
AN:
38556
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
10288
20576
30863
41151
51439
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3580
7160
10740
14320
17900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.375 AC: 57063AN: 152066Hom.: 10717 Cov.: 33 AF XY: 0.373 AC XY: 27714AN XY: 74346 show subpopulations
GnomAD4 genome
AF:
AC:
57063
AN:
152066
Hom.:
Cov.:
33
AF XY:
AC XY:
27714
AN XY:
74346
show subpopulations
African (AFR)
AF:
AC:
17915
AN:
41484
American (AMR)
AF:
AC:
4854
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1373
AN:
3466
East Asian (EAS)
AF:
AC:
2000
AN:
5164
South Asian (SAS)
AF:
AC:
1995
AN:
4812
European-Finnish (FIN)
AF:
AC:
3767
AN:
10580
Middle Eastern (MID)
AF:
AC:
155
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23831
AN:
67972
Other (OTH)
AF:
AC:
881
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1910
3820
5730
7640
9550
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
564
1128
1692
2256
2820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1564
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Sep 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.